MATHEW ABY J. (EVP & Chief Scientific Officer) received a stock award from BIOLIFE SOLUTIONS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 10/9/2026ACC: 0001193125-26-418315
Officer· EVP & Chief Scientific Officer
Since Mar 2026
-388.58K
Net shares
Net seller
$2.70M
Total sold
0
Open market trades
0B · 0S
4
Total transactions
86.03K acquired · 474.61K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+45.84K
Price / share
—
Trade value
—
% of position
15.4%
10/6/2026
298.03K→343.87K
Common Stock
Direct
Shares
+40.19K
Price / share
—
Trade value
—
% of position
11.7%
10/6/2026
343.87K→384.06K
Common Stock
Direct
Shares
−70K
Price / share
$38.61
Trade value
$2.70M
% of position
18.2%
10/6/2026
384.06K→314.06K
Common Stock
Direct
Shares
−404.61K
Price / share
—
Trade value
—
% of position
New position
10/6/2026
404.61K→0.00
Total
Net shares
−388.58K
Net value
-$2.70M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/6/2026 | A · Award | +45.84K | — | — | 15.4% | 298.03K | 343.87K |
| Common Stock Direct | 10/6/2026 | A · Award | +40.19K | — | — | 11.7% | 343.87K | 384.06K |
| Common Stock Direct | 10/6/2026 | F · Tax Withholding | −70K | $38.61 | $2.70M | 18.2% | 384.06K | 314.06K |
| Common Stock Direct | 10/6/2026 | D · Disposition | −404.61K | — | — | New position | 404.61K | 0.00 |
| Total | −388.58K | -$2.70M | ||||||
Derivative Transactions0
No derivative transactions reported